For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase III Clinical Research

Trial Profile

For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase III Clinical Research

Recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Mycobacterium riyadhense (Primary)
  • Indications Tuberculosis
  • Focus Diagnostic use; Registrational
  • Sponsors AnHui Longcom Biologic Pharmacy
  • Most Recent Events

    • 05 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.
    • 05 Jan 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2017.
    • 04 May 2016 Planned End Date changed from 1 May 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top